Tech group opposes offshoring bill
Rick Merritt, EETimes
9/27/2010 1:06 PM EDT
SAN JOSE, Calif. – The TechAmerica industry group has come out in opposition to a draft bill in the U.S. Senate that claims it will end the practice of offshoring jobs. A vote on the bill in the Senate is expected this week.Richard J. Durbin (D-Ill.) and seven other Democratic senators sponsor the Creating American Jobs and Ending Offshoring Act (S. 3816) which was introduced in the Senate September 21. This legislation would, among other things, end tax deferral for so-called imported property income of controlled foreign corporations (CFCs).
![]() |
E-mail This Article | ![]() |
![]() |
Printer-Friendly Page |
Related News
- Biden-Harris Administration Announces Preliminary Terms with Intel to Support Investment in U.S. Semiconductor Technology Leadership and Create Tens of Thousands of Jobs
- GlobalFoundries Officially Opens US$4 Billion Expansion Facility in Singapore, Creating 1,000 New Jobs
- Sondrel engages The SHD Group to assist in bringing Architecting the Future to the American market
- Opinion: CHIPS Act Escalates Long-Standing U.S.-China Tech Rivalry
- Nordic Semiconductor expands into Wi-Fi by acquiring the entire Wi-Fi development team, core Wi-Fi expertise, and Wi-Fi IP tech assets of Imagination Technologies Group
Breaking News
- RISC-V International Promotes Andrea Gallo to CEO
- See the 2025 Best Edge AI Processor IP at the Embedded Vision Summit
- Andes Technology Showcases RISC-V AI Leadership at RISC-V Summit Europe 2025
- RISC-V Royalty-Driven Revenue to Exceed License Revenue by 2027
- Keysom Unveils Keysom Core Explorer V1.0
Most Popular
- RISC-V International Promotes Andrea Gallo to CEO
- See the 2025 Best Edge AI Processor IP at the Embedded Vision Summit
- Andes Technology Showcases RISC-V AI Leadership at RISC-V Summit Europe 2025
- Ceva, Inc. Announces First Quarter 2025 Financial Results
- Cadence Unveils Millennium M2000 Supercomputer with NVIDIA Blackwell Systems to Transform AI-Driven Silicon, Systems and Drug Design